Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
about
Neuroimaging biomarkers of neurodegenerative diseases and dementiaNeuroimaging of dementia in 2013: what radiologists need to know.Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.A Hierarchical Bayesian Model for the Identification of PET Markers Associated to the Prediction of Surgical Outcome after Anterior Temporal Lobe Resection.Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.
P2860
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@ast
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@en
type
label
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@ast
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@en
prefLabel
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@ast
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@en
P2860
P1476
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.
@en
P2093
Daniel H S Silverman
Nare Torosyan
P2860
P304
P356
10.1053/J.SEMNUCLMED.2012.06.004
P577
2012-11-01T00:00:00Z